A critical appraisal of daclizumab use as emerging therapy in multiple sclerosis. [electronic resource]
Producer: 20160318Description: 1157-68 p. digitalISSN:- 1744-764X
- Antibodies, Monoclonal, Humanized -- immunology
- Clinical Trials as Topic
- Daclizumab
- Drug Monitoring
- Humans
- Immunoglobulin G -- immunology
- Immunosuppressive Agents -- immunology
- Interleukin-2 Receptor alpha Subunit -- antagonists & inhibitors
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.